Lipocine Inc. has initiated the BLOOM Phase 3 clinical trial to evaluate LPCN 1154, an oral brexanolone treatment for severe postpartum depression (PPD). The study plans to enroll about 120 participants, aiming to provide rapid symptom relief through a 48-hour at-home oral regimen. This trial follows a prior Phase 3 study that showed safety but did not meet primary endpoints, with new measures to improve data quality and reduce placebo effects. Lipocine expects to fund the study with existing resources and aims to support a future regulatory submission if results are positive.
Lipocine's new Phase 3 study initiation is the focus, with Pluang data showing a breadth of 91 priced US health-sector stocks, where 50 rose and 28 fell as of Sep 14, 2026 18:52 WIB. Among notable movers, Sanofi SA (SNY) rose 1.71% to USD 43.50, while Aurora Cannabis Inc (ACB) and Recursion Pharmaceuticals Inc (RXRX) fell 1.74% and 1.72% respectively, priced at USD 3.67 and USD 3.15.
At the 2026 Paris Motor Show, Chery introduced its "For EU. For Family" strategy, tailored to meet European families' mobility needs with a focus on space, safety, and technology. The company showcased a range of vehicles including its first battery-...
Publicis Groupe delivered a robust Q3 2026 with a 5% organic growth in net revenue, accelerating from the first half of the year. Key growth drivers included Connected Media and Intelligent Creativity, fueled by AI-driven services and strong new busi...
TomTom has introduced Electric Vehicle Management, a self-service platform that allows automakers to onboard new EV models in minutes by submitting vehicle specs. This platform connects vehicles to TomTom's comprehensive EV suite, which includes AI-p...
Publicis Groupe reported a 5% organic growth in net revenue for Q3 2026, accelerating from the first half of the year, driven by strong performance in Connected Media and Intelligent Creativity. The company confirmed its full-year 2026 guidance with ...
Czechoslovak Group (CSG) has entered the space sector by acquiring a 9.5% equity stake in MDA Space Ltd., making it the largest shareholder. MDA Space is a leading global space technology company listed on the Toronto and New York stock exchanges. Th...
